HealthDay - TUESDAY, Sept. 23 (HealthDay News) -- Nasally administered insulinwon't protect children at high risk of developing type 1 diabetes fromgetting the illness, Finnish researchers say.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.